Immunologic reactivity was measured in 344 patients with nasopharyngeal carcinoma (NPC), before treatment, and in 398 age-matched control subjects. The data recorded suggest that depressed cell-mediated immunity in patients with NPC is a consequence rather than a cause of the disease. In order to reduce tumor burden in patients with NPC, radiation therapy with chemotherapy or immunopotentiation or both is recommended.
Get full access to this article
View all access options for this article.
References
1.
MaisalRHOguraJH: Abnormal dinitrochlorobenzene skin sensitization: A prognostic sign of survival in head and neck squamous cell carcinoma, Laryngoscope83:2012–2019, 1973.
2.
StefaniSKermanRAbbateJ: Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy. Am J Roentgenol126:880–886, 1976.
3.
DeeganMJCoulthardSWQualmanSJ: A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck. Cancer Res37:4475–4481, 1977.
4.
RaflaSYangSJMelekaF: Changes in cell-mediated immunity in patients undergoing radiotherapy. Cancer41:1076–1086, 1978.
5.
ShanmugaratnamK: Histological typing of nasopharyngeal carcinoma, in De-TheGItoY (eds): Nasopharyngeal Carcinoma: Etiology and Control. Lyon, France, IARC, 1978, pp 3–12.
6.
HenleWHenleGHoHC: Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst44:225–231, 1970.
7.
CatalonaWJChretienPB: Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: Correlation with tumor stage and histology. Cancer31:353–356, 1973.
8.
HsuMMLoRJLynnTC: Cellular immunity in nasopharyngeal carcinoma. I. Relationship between purified protein derivative test and leukocyte migration test. J Formosan Med Assoc74:517–524, 1975.
9.
BöyumA: Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest21(suppl 97): 77–89, 1968.
10.
HsuMMWangKRLynnTC: Cellular immunity in nasopharyngeal carcinoma. III. Lymphocyte subpopulations and lymphocyte response to phytohemagglutinin. J Formosan Med Assoc77:549–555, 1978.
11.
PerezCAAckermanLVMillWB: Cancer of the nasopharynx: Factors influencing prognosis. Cancer24:1–17, 1969.
12.
McCoyJLJeromeLFDeanJH: Inhibition of leukocyte migration by tumor-associated antigens and soluble extracts of human breast carcinoma. J Natl Cancer Inst53:11–17, 1974.
13.
SampleWFCertnerHRJr.ChretienPB: Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma. J Natl Cancer Inst46:1291–1297, 1971.
14.
EilberFRMortonDLKetchamAS: Immunologic abnormalities in head and neck cancer. Am J Surg128:534–538, 1974.
15.
SilvermanNAAlexanderJCJr.HollinsheadAC: Correlation of tumor burden with in vitro lymphocyte reactivity and anti-bodies to herpes virus tumor-associated antigens in head and neck squamous carcinoma. Cancer37:135–140, 1976.
